Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis
- 31 December 1990
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 11, S113-S117
- https://doi.org/10.1016/0168-8278(90)90175-q
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Interferon Therapy for Chronic Type B Hepatitis: The Promise Comes of AgeGastroenterology, 1989
- Prednisone Withdrawal Followed by Recombinant Alpha Interferon in the Treatment of Chronic Type B HepatitisAnnals of Internal Medicine, 1988
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Interferon in viral hepatitis: Role in pathogenesis and treatmentHepatology, 1986
- Approaches to the Treatment of Hepatitis B Virus and Delta-Related Liver DiseaseSeminars in Liver Disease, 1986
- Pilot study of recombinant human α-interferon for chronic type B hepatitisGastroenterology, 1986
- Recombinant Leukocyte A Interferon Treatment in Patients With Chronic Hepatitis B Virus InfectionGastroenterology, 1985
- Detection of Hepatitis B Virus DNA Directly in Human Serum by a Simplified Molecular Hybridization Test: Comparison to HBeAg/ Anti-HBe Status in HBsAg Carriers†Hepatology, 1983
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981
- SERUM LEVELS OF HEPATITIS B SURFACE AND CORE ANTIGENS DURING IMMUNOSUPPRESSIVE TREATMENT OF HBsAg-POSITIVE CHRONIC ACTIVE HEPATITISThe Lancet, 1980